analytica Vietnam records exhibitor rush
Since the first event in 2009, analytica Vietnam has established itself as the lead-ing trade fair for laboratory technology, analysis, biotechnology and diagnostics in the region. Among the exhibitors who have already confirmed their participation for next year there are national and international market leaders such as Agilent, Eppendorf, Merck, Metrohm, Mettler Toledo, Shimadzu, Saigon Instruments, and Waters. In 2019 there will moreover be four country pavilions from Germany, China, Taiwan and Singapore.
First-hand information
During the lab tours, visitors to the fair will have the opportunity to gain an insight into the equipment of Vietnamese laboratories, and to obtain first-hand infor-mation about the country's research and laboratory technology. These guided tours take place on the two days before the official opening of the fair and take the participants to selected research institutions and companies, where they can visit laboratories and exchange ideas with the staff.
In order to quickly establish the right business contacts at the trade fair, the or-ganizer once again offers buyer–seller meetings, at which exhibitors and visitors are brought together without much ado in 20-minute meetings. Here, representa-tives of the exhibiting companies indicate in advance which sectors and compa-nies are of potential interest to them. The trade fair organizer then arranges the meetings, which are free of charge and take place in a separate area of the event.
Vietnam's economy is booming
Vietnam is a promising market in particular for the analytics, laboratory and bio-technology sector. In no other country in the ASEAN region is the economy grow-ing so fast; the Asian Development Bank is predicting an increase of 6.7 percent for 2018. With increasing prosperity in society, the healthcare system is expand-ing and the pharmaceutical industry booming. Food safety is becoming increas-ingly important in the victuals industry. Vietnam's many other export products, for example from the textile and clothing industry, are by now likewise subject to in-ternational testing standards. Accordingly, there is a great need for suitable la-boratory and analytical equipment, most of which the country still has to import. "With analytica Vietnam, we are providing the proper platform for bringing demand and supply together", says Gabriele Kraus, Executive Director at the trade fair organizer IMAG. Experts expect the free trade agreement between the EU and Vietnam, which is scheduled to enter into force at the beginning of 2019, to pro-vide a further boost to the Vietnamese economy.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
analytica preview 2024
Here, innovative exhibitors present their trade fair innovations, premieres and product innovations for analytica 2024.
analytica preview 2024
Here, innovative exhibitors present their trade fair innovations, premieres and product innovations for analytica 2024.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.